June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Effect of HMG-CoA reductase inhibitor(statins) on the expression of catalase in human retinal pigment epithelial cells
Author Affiliations & Notes
  • Min Gu Kang
    Department of Ophthalmology and Inha Vision Science Laboratory, Inha University School of Medicine, Incheon, Republic of Korea
  • So Young Lee
    Department of Ophthalmology and Inha Vision Science Laboratory, Inha University School of Medicine, Incheon, Republic of Korea
  • Na Rae Kim
    Department of Ophthalmology and Inha Vision Science Laboratory, Inha University School of Medicine, Incheon, Republic of Korea
  • Hee Seung Chin
    Department of Ophthalmology and Inha Vision Science Laboratory, Inha University School of Medicine, Incheon, Republic of Korea
  • Footnotes
    Commercial Relationships Min Gu Kang, None; So Young Lee, None; Na Rae Kim, None; Hee Seung Chin, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4620. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Min Gu Kang, So Young Lee, Na Rae Kim, Hee Seung Chin; Effect of HMG-CoA reductase inhibitor(statins) on the expression of catalase in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4620.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the effects of HMG-CoA reductase inhibitor(statins) on the expression of catalase in human retinal pigment epithelial cells.

Methods: RPE cells were incubated for 6 hours with various concentrations (0, 1, 2.5, 5, 10µM) of simvastatin. After 6 hours of incubation, real time PCR was peformed to evaluate the expression of catalase mRNA and western blot was performed to evaluate the expression of catalase in RPE cells.

Results: Catalase and catalase mRNA were maximally expressed when the human RPE cells treated with 10µM of simvastatin for 6 hours. Also the human RPE cells showed concentration-dependent expression of catalase and catalase mRNA when treated with concentrations of simvastatin for 6 hours.

Conclusions: Simvastatin upregulates the expression of catalase in human RPE cells. Simvastatin may have some clinical benefits in preventing retinal diseases associated with oxidative stress, such as age-related macular degeneration.

Keywords: 701 retinal pigment epithelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×